Sartorius Stedim Biotech S.A. (FRA:56S1)

Sartorius Stedim Biotech Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	298.7	678.9	116.6	107.1	223.6	59.76
Short-Term Investments	-	9.9	9.5	24.8	12.7	9.84
Cash & Short-Term Investments	298.7	688.8	126.1	131.9	236.3	69.61
Cash Growth	-38.11%	446.23%	-4.40%	-44.18%	239.49%	90.47%
Accounts Receivable	226	265.9	293.7	404.6	356	256.89
Other Receivables	23.2	33.8	39.8	14	14.7	6.06
Receivables	249.2	300.6	334.4	419.7	371.7	263.96
Inventory	723.1	684.9	882.4	1,025	783	471.03
Other Current Assets	110.7	66.7	72.2	94.8	64.6	69.34
Total Current Assets	1,382	1,741	1,415	1,671	1,456	873.95
Property, Plant & Equipment	1,974	1,163	1,036	808	640.2	518.6
Long-Term Investments	22.8	24	40.8	24.9	14.8	-
Goodwill	2,881	2,908	2,885	1,136	820.7	725.15
Other Intangible Assets	1,546	1,361	1,465	712.1	563.3	473.83
Long-Term Deferred Tax Assets	70.7	63.2	60	61.6	46.5	27.48
Long-Term Deferred Charges	-	269	227.8	164.2	120.9	98.05
Other Long-Term Assets	2.7	727.6	601	487	289.1	139.68
Total Assets	7,880	8,256	7,730	5,065	3,951	2,857
Accounts Payable	281.1	310	258.5	251.5	251.4	174.73
Accrued Expenses	105.3	88.2	62.3	74.1	97.2	59.9
Current Portion of Long-Term Debt	526.4	39.5	57.7	4.5	25.5	13.11
Current Portion of Leases	23.1	25	21.4	19.5	14.9	10.88
Current Income Taxes Payable	84.4	123.2	189.4	209.6	165	71.52
Current Unearned Revenue	175.3	216.1	238.6	271	259.6	156.76
Other Current Liabilities	115.2	136.8	109.4	205.7	223.5	80.94
Total Current Liabilities	1,311	938.8	937.3	1,036	1,037	567.84
Long-Term Debt	1,867	2,684	3,510	1,021	521.1	515.66
Long-Term Leases	146.8	120.6	93.1	91.1	64	47.46
Pension & Post-Retirement Benefits	33.7	39.3	34.6	35.6	46.8	49.55
Long-Term Deferred Tax Liabilities	355.5	358.2	389.4	178.3	125.8	85.08
Other Long-Term Liabilities	93.7	91.3	92.2	189.7	423	130.15
Total Liabilities	3,807	4,233	5,056	2,551	2,218	1,396
Common Stock	19.5	19.5	18.4	18.4	18.4	18.44
Retained Earnings	2,593	2,496	2,391	2,179	1,397	1,209
Comprehensive Income & Other	1,424	1,471	229	251.9	240.2	210.42
Total Common Equity	4,036	3,987	2,639	2,449	1,656	1,438
Minority Interest	36.1	37.2	35.3	64.9	77.4	22.88
Shareholders' Equity	4,072	4,024	2,674	2,514	1,733	1,461
Total Liabilities & Equity	7,880	8,256	7,730	5,065	3,951	2,857
Total Debt	2,563	2,870	3,682	1,136	625.5	587.11
Net Cash (Debt)	-2,264	-2,181	-3,556	-1,004	-389.2	-517.5
Net Cash Per Share	-23.25	-22.53	-38.58	-10.89	-4.22	-5.61
Filing Date Shares Outstanding	97.27	97.3	92.16	92.16	92.18	92.18
Total Common Shares Outstanding	97.27	97.3	92.16	92.16	92.18	92.18
Working Capital	70.9	802.2	477.8	635.3	418.5	306.11
Book Value Per Share	41.49	40.97	28.63	26.58	17.96	15.60
Tangible Book Value	-391.2	-282.4	-1,711	600.8	271.9	239.15
Tangible Book Value Per Share	-4.02	-2.90	-18.57	6.52	2.95	2.59
Land	-	803.1	707.8	509.1	426.2	351.65
Machinery	-	796.2	688.5	581.3	469.7	384.92
Order Backlog	-	1,482	1,495	1,844	1,915	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.